Sleep Apnea Implants Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Sleep Apnea Implants Market size was valued at USD 461.2 million in 2023 and is anticipated to witness growth at a CAGR of 14.8% between 2024 and 2032. The market is experiencing growth driven by the increasing prevalence of obstructive sleep apnea, low compliance & adherence towards CPAP, and rising awareness regarding sleep apnea.
The surging global prevalence of obstructive sleep apnea (OSA) is significantly propelling the expansion of the sleep apnea implant market. According to the National Institutes of Health (NIH), approximately 936 million adults aged 30-69 years are affected by OSA globally. With OSA impacting diverse demographics worldwide, the demand for effective treatment solutions is intensifying. Additionally, this rising global challenge of OSA is fueling an increased demand for innovative therapies, including sleep apnea implants, which promise long-term management of the condition.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Sleep Apnea Implants Market size in 2023: | USD 461.2 Million |
Forecast Period: | 2024 – 2032 |
Forecast Period 2023 - 2032 CAGR: | 14.8 |
2023 Value Projection: | USD 1.7 Billion |
Historical Data for: | 2021-2023 |
No of Pages: | 100 |
Tables, Charts & Figures: | 100 |
Segments Covered: | Product, Indication, End-use, and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
Furthermore, as awareness of obstructive sleep apnea and its associated health risks grows, more individuals are seeking medical evaluation and diagnosis. This has led to an increase in the identification of OSA cases, driving the demand for treatment options. Sleep apnea implants, which offer a long-term solution for patients who cannot tolerate continuous positive airway pressure (CPAP) therapy, are becoming a popular choice among diagnosed individuals.
Sleep apnea implants are medical devices surgically implanted in patients to treat moderate to severe cases of sleep apnea. These implants work by stimulating specific nerves, muscles, or tissues to maintain an open airway during sleep, preventing the repetitive pauses in breathing that characterize sleep apnea.
Innovations in medical technology have led to the development of more effective, minimally invasive, and patient-friendly solutions for managing obstructive sleep apnea (OSA).
Based on product, the market is segmented into hypoglossal neurostimulation devices, palatal implants, bone screw systems, and phrenic nerve stimulators. The hypoglossal neurostimulation devices segment held a dominant market share of 88.8% in 2023.
Based on indication, the sleep apnea implants market is classified into central sleep apnea and obstructive sleep apnea. The obstructive sleep apnea segment accounted for the highest market share and was valued at USD 432 million in 2023.
Based on end-use, the sleep apnea implants market is categorized into hospitals, ambulatory surgical centers, and other end-users. The ambulatory surgical centers (ASCs) held a considerable share in 2023, and the segment is projected to reach USD 651.4 million by 2032.
The North America sleep apnea implants market size in 2023 was valued at USD 358.3 million and is predicted to grow at a CAGR of 14.3% over the analysis timeframe.
The U.S. sleep apnea implants market is anticipated to reach USD 1.2 billion by the end of the forecast timeframe.
Germany sleep apnea implants market is projected to grow remarkably in the coming years.
France is experiencing high market growth in the market.
The sleep apnea implants industry is characterized by the presence of several established and emerging players that offer a variety of products across the globe. The market players compete based on factors such as product quality, innovation, regulatory compliance, customer service, and pricing strategies.
Prominent players operating in the sleep apnea implants industry include:
Market, By Product
Market, By Indication
Market, By End-use
The above information is provided for the following regions and countries:
North America sleep apnea implants industry was valued at USD 358.3 million in 2023 and is predicted to record a CAGR of 14.3% through 2032, attributed to the high prevalence of sleep apnea, well-established healthcare infrastructure, and growing public awareness.
Sleep apnea implants industry was valued at USD 461.2 million in 2023 and is anticipated to witness a CAGR of 14.8% through 2032, driven by the increasing prevalence of obstructive sleep apnea, low compliance & adherence towards CPAP, and rising awareness regarding sleep apnea.
Asahi Kasei Corporation, Inspire Medical System, Medtronic plc, Nyxoah SA, and Siesta Medical, Inc. among others.
The obstructive sleep apnea segment was valued at USD 432 million in 2023 and will grow as it provides a more comfortable and effective long-term solution, and preference among healthcare providers.